CTP-18-C-0144-experimental study to test acute nicotine toxicity warnings for E-liquids on consumer knowledge and perceptions BPA call against multiple award BPA HHSF223201510001B 10002B 10003B

Ended Awarded Last action

Contract number
75F40118F18002
Awardee
Awarding agency
Obligated
$100,550

Award facts

Contract value 100% obligated
$100,550.30 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Arlington, VA 22201, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00009 · Correct payment terms to net 30 -experimental study to test acute nicotine toxicity warnings for E-liquids on consumer knowledge and perceptions BPA call $0
Other Administrative Action P00008 -$255,431
Other Administrative Action P00007 · Changing the contracting officer representative (COR) from ranjeeta gupta to ayobodun bello. $0
Other Administrative Action P00006 $0
Supplemental Agreement for work within scope P00005 $0
Other Administrative Action P00004 · Changing the contracting officer representative (COR) from nicholas hasbrouck to ranjeeta gupta. $0
Other Administrative Action P00003 -$624
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $356,605

About this award

The Food and Drug Administration awarded a BPA call contract to Fors Marsh Group LLC under the Advertising & Integrated Marketing Solutions (AIMS) GSA Schedule for an experimental study to test acute nicotine toxicity warnings for e-liquids on consumer knowledge and perceptions. This firm fixed-price contract, valued at $100,550.30, was awarded on September 26, 2018, with a completion date of December 24, 2022. The contract falls under the Quick Turnaround Social Science Research Services program and does not include a small business set-aside designation. Performance was executed in Arlington, Virginia, where Fors Marsh Group maintains its headquarters.

Fors Marsh Group LLC, a certified B Corporation specializing in research, market research, and strategic communications, was well-positioned to execute this work given its extensive portfolio of federal contracts with agencies including the Centers for Disease Control and Prevention, National Institutes of Health, and others. The study directly supports the FDA's regulatory mission regarding e-liquid product labeling and consumer safety communications, addressing the agency's need to understand how warning label design influences consumer perception of nicotine toxicity risks. This research initiative reflects the FDA's broader mandate to inform regulatory policy on emerging tobacco products through evidence-based social science research.

Quick answers

Who was awarded contract 75F40118F18002?

75F40118F18002 was awarded to Fors Marsh Group LLC by Food and Drug Administration (Department of Health and Human Services) on September 26, 2018.

How much is contract 75F40118F18002 worth?

The government has obligated $100,550 on 75F40118F18002.

Is contract 75F40118F18002 an order under another contract?

Yes. 75F40118F18002 is a BPA call under GS23F0242R-HHSF223201510003B, a blanket purchase agreement, on Advertising & Integrated Marketing Solutions (AIMS).

Was contract 75F40118F18002 competed?

The extent of competition for 75F40118F18002 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award